Showing posts with label standard of care. Show all posts
Showing posts with label standard of care. Show all posts
Thursday, December 27, 2012
Demystifying Routine Care Coverage in Trial Budgeting
Thought Leaders: Jessica Dolfi, MS, Senior Business Consultant, Medidata Solutions Worldwide and Kelly Willenberg, MBA, BSN, CHRC, CHC, Kelly Willenberg, LLC
In this episode, we discuss standard of care in clinical trials, challenges for sites and sponsors, and how standard of care issues affect day-to-day work in trials.
For more information about Medidata Solutions Worldwide, visit www.mdsol.com.
Play Podcast.
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Labels:
clinical trials,
healthcare,
medidata,
podcast,
standard of care
Wednesday, January 04, 2012
The C-Suite: How Biotech Improves the Standard of Care of Patients
Thought Leader: Brad Thompson, Ph.D., Chairman, President and CEO, Oncolytics Biotech
In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.
Play Podcast
In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.
Play Podcast
For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.
Subscribe to:
Posts (Atom)